235 related articles for article (PubMed ID: 30515560)
1. Economic Analysis of a Three-Arm RCT Exploring the Delivery of Intensive, Prophylactic Swallowing Therapy to Patients with Head and Neck Cancer During (Chemo)Radiotherapy.
Wall LR; Kularatna S; Ward EC; Cartmill B; Hill AJ; Isenring E; Byrnes J; Porceddu SV
Dysphagia; 2019 Oct; 34(5):627-639. PubMed ID: 30515560
[TBL] [Abstract][Full Text] [Related]
2. Adherence to a Prophylactic Swallowing Therapy Program During (Chemo) Radiotherapy: Impact of Service-Delivery Model and Patient Factors.
Wall LR; Ward EC; Cartmill B; Hill AJ; Porceddu SV
Dysphagia; 2017 Apr; 32(2):279-292. PubMed ID: 27844152
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial.
Wall LR; Ward EC; Cartmill B; Hill AJ; Isenring E; Byrnes J; Porceddu SV
Head Neck; 2020 May; 42(5):873-885. PubMed ID: 31903689
[TBL] [Abstract][Full Text] [Related]
4. Examining user perceptions of SwallowIT: A pilot study of a new telepractice application for delivering intensive swallowing therapy to head and neck cancer patients.
Wall LR; Ward EC; Cartmill B; Hill AJ; Porceddu SV
J Telemed Telecare; 2017 Jan; 23(1):53-59. PubMed ID: 26670210
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of a speech pathology synchronous telepractice service for patients with head and neck cancer.
Burns CL; Kularatna S; Ward EC; Hill AJ; Byrnes J; Kenny LM
Head Neck; 2017 Dec; 39(12):2470-2480. PubMed ID: 28963804
[TBL] [Abstract][Full Text] [Related]
6. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
Martino R; Fitch MI; Fuller CD; Hope A; Krisciunas G; Langmore SE; Lazarus C; Macdonald CL; McCulloch T; Mills G; Palma DA; Pytynia K; Ringash J; Sultanem K; Theurer J; Thorpe KE; Hutcheson K
BMC Cancer; 2021 Oct; 21(1):1100. PubMed ID: 34645411
[TBL] [Abstract][Full Text] [Related]
7. Implementation of speech pathology telepractice services for clinical swallowing assessment: An evaluation of service outcomes, costs and consumer satisfaction.
Burns CL; Ward EC; Gray A; Baker L; Cowie B; Winter N; Rusch R; Saxon R; Barnes S; Turvey J
J Telemed Telecare; 2019 Oct; 25(9):545-551. PubMed ID: 31631757
[TBL] [Abstract][Full Text] [Related]
8. Application of telepractice for head and neck cancer management: a review of speech language pathology service models.
Ward EC; Wall LR; Burns CL; Cartmill B; Hill AJ
Curr Opin Otolaryngol Head Neck Surg; 2017 Jun; 25(3):169-174. PubMed ID: 28319481
[TBL] [Abstract][Full Text] [Related]
9. Home-based telehealth service for swallowing and nutrition management following head and neck cancer treatment.
Collins A; Burns CL; Ward EC; Comans T; Blake C; Kenny L; Greenup P; Best D
J Telemed Telecare; 2017 Dec; 23(10):866-872. PubMed ID: 29081270
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial).
Baudelet M; Van den Steen L; Duprez F; De Bodt M; Deschuymer S; Goeleven A; Hutsebaut I; Mariën S; Meersschout S; Nevens D; Nuyts S; Peeters M; Specenier P; Van den Brekel M; van der Molen L; Vandenbruaene C; Vanderveken O; Van Dinther J; Van Laer C; Vauterin T; Verstraete H; Van Nuffelen G;
Trials; 2020 Mar; 21(1):237. PubMed ID: 32122397
[TBL] [Abstract][Full Text] [Related]
11. Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.
Guillen-Sola A; Soler NB; Marco E; Pera-Cegarra O; Foro P
Trials; 2019 Aug; 20(1):503. PubMed ID: 31412947
[TBL] [Abstract][Full Text] [Related]
12. Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-Trial.
Baudelet M; Duprez F; Van den Steen L; Nuyts S; Nevens D; Goeleven A; Vandenbruaene C; Massonet H; Vergauwen A; Bollen H; Deschuymer S; Wouters K; Peeters M; Van Laer C; Mariën S; Van den Brekel M; van der Molen L; Vauterin T; van Dinther J; Verstraete H; Hutsebaut I; Meersschout S; Vanderveken O; De Bodt M; Van Nuffelen G;
Dysphagia; 2023 Jun; 38(3):886-895. PubMed ID: 36121560
[TBL] [Abstract][Full Text] [Related]
13. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
[TBL] [Abstract][Full Text] [Related]
14. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes.
Burns CL; Ward EC; Hill AJ; Kularatna S; Byrnes J; Kenny LM
Head Neck; 2017 May; 39(5):932-939. PubMed ID: 28225567
[TBL] [Abstract][Full Text] [Related]
17. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a weekly speech pathology/dietetic service model for providing supportive care intervention to head and neck cancer patients and their carers during (chemo)radiotherapy.
Wall LR; Cartmill B; Ward EC; Hill AJ; Isenring E; Porceddu SV
Support Care Cancer; 2016 Mar; 24(3):1227-34. PubMed ID: 26304158
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC.
Moroney LB; Ward EC; Helios J; Crombie J; Burns CL; Blake C; Comans T; Chua B; Kenny L; Hughes BGM
Support Care Cancer; 2020 Apr; 28(4):1867-1876. PubMed ID: 31352509
[TBL] [Abstract][Full Text] [Related]
20. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment.
Starmer HM; Tippett D; Webster K; Quon H; Jones B; Hardy S; Gourin CG
Head Neck; 2014 Oct; 36(10):1392-7. PubMed ID: 24038454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
